» Articles » PMID: 33723764

Craniofacial Development: Neural Crest in Molecular Embryology

Overview
Specialties Oncology
Pathology
Date 2021 Mar 16
PMID 33723764
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Craniofacial development, one of the most complex sequences of developmental events in embryology, features a uniquely transient, pluripotent stem cell-like population known as the neural crest (NC). Neural crest cells (NCCs) originate from the dorsal aspect of the neural tube and migrate along pre-determined routes into the developing branchial arches and frontonasal plate. The exceptional rates of proliferation and migration of NCCs enable their diverse contribution to a wide variety of craniofacial structures. Subsequent differentiation of these cells gives rise to cartilage, bones, and a number of mesenchymally-derived tissues. Deficiencies in any stage of differentiation can result in facial clefts and abnormalities associated with craniofacial syndromes. A small number of conserved signaling pathways are involved in controlling NC differentiation and craniofacial development. They are used in a reiterated fashion to help define precise temporospatial cell and tissue formation. Although many aspects of their cellular and molecular control have yet to be described, it is clear that together they form intricately integrated signaling networks required for spatial orientation and developmental stability and plasticity, which are hallmarks of craniofacial development. Mutations that affect the functions of these signaling pathways are often directly or indirectly identified in congenital syndromes. Clinical applications of NC-derived mesenchymal stem/progenitor cells, persistent into adulthood, hold great promise for tissue repair and regeneration. Realization of NCC potential for regenerative therapies motivates understanding of the intricacies of cell communication and differentiation that underlie the complexities of NC-derived tissues.

Citing Articles

Targeting stromal cells in tumor microenvironment as a novel treatment strategy for glioma.

Geng Z, Zhang Z, Wang M, Yu Z, Wang S, Lu J Cancer Cell Int. 2025; 25(1):58.

PMID: 39985022 PMC: 11846374. DOI: 10.1186/s12935-025-03692-3.


Jansen metaphyseal chondrodysplasia: analysis of craniofacial manifestations.

Obiezu F, Almpani K, Kim H, Zalewski C, Chu E, Jahanmir G JBMR Plus. 2025; 9(2):ziae156.

PMID: 39830149 PMC: 11736719. DOI: 10.1093/jbmrpl/ziae156.


Redefining retinoic acid receptor expression in zebrafish embryos using Hybridization Chain Reaction.

Gray R, Lovely C Differentiation. 2024; 140:100822.

PMID: 39627912 PMC: 11653530. DOI: 10.1016/j.diff.2024.100822.


Epithelial-mesenchymal crosstalk: the scriptwriter of craniofacial morphogenesis.

Lu J, Peng B, Wang W, Zou Y Front Cell Dev Biol. 2024; 12:1497002.

PMID: 39583201 PMC: 11582012. DOI: 10.3389/fcell.2024.1497002.


TGF-β signaling in the cranial neural crest affects late-stage mandibular bone resorption and length.

Houchen C, Ghanem S, Kaartinen V, Bumann E Front Physiol. 2024; 15:1435594.

PMID: 39473613 PMC: 11519526. DOI: 10.3389/fphys.2024.1435594.


References
1.
Zhang G, Li Q, Yuan Q, Zhang S . Spatial Distributions, Characteristics, and Applications of Craniofacial Stem Cells. Stem Cells Int. 2020; 2020:8868593. PMC: 7475745. DOI: 10.1155/2020/8868593. View

2.
Moss M, BROMBERG B, Song I, Eisenman G . The passive role of nasal septal cartilage in mid-facial growth. Plast Reconstr Surg. 1968; 41(6):536-42. DOI: 10.1097/00006534-196806000-00004. View

3.
Zhang S, Yap A, Toh W . Stem Cells for Temporomandibular Joint Repair and Regeneration. Stem Cell Rev Rep. 2015; 11(5):728-42. DOI: 10.1007/s12015-015-9604-x. View

4.
Danescu A, Mattson M, Dool C, Diewert V, Richman J . Analysis of human soft palate morphogenesis supports regional regulation of palatal fusion. J Anat. 2015; 227(4):474-86. PMC: 4580105. DOI: 10.1111/joa.12365. View

5.
Graf D, Malik Z, Hayano S, Mishina Y . Common mechanisms in development and disease: BMP signaling in craniofacial development. Cytokine Growth Factor Rev. 2016; 27:129-39. PMC: 4753105. DOI: 10.1016/j.cytogfr.2015.11.004. View